PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) has announced it will host a webcast conference call on Thursday, November 7, at 4:30 p.m. EST to discuss its third quarter 2024 financial results and provide a business update. Participants are advised to register in advance and dial in 15 minutes before the call to avoid delays. The webcast will be accessible through PTC's Investor Relations website, with a replay available for 30 days after the call.

News Market Reaction

-2.54%

1 alert

-2.54% News Effect

On the day this news was published, PTCT declined 2.54%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

WARREN, N.J., Oct. 24, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its third quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, Nov. 7, at 4:30 p.m. EST.

To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.

About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on X (formerly Twitter), and on LinkedIn. 

For More Information: 

Investors: 
Investor Relations 
+1 (908) 912-9848
ir@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-third-quarter-2024-financial-results-302285326.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics (PTCT) report Q3 2024 earnings?

PTC Therapeutics will report its third quarter 2024 financial results on Thursday, November 7, at 4:30 p.m. EST.

How can I access PTC Therapeutics (PTCT) Q3 2024 earnings call?

You can access the call by registering for dial-in details or through the webcast on PTC's Investor Relations website at https://ir.ptcbio.com/events-presentations.

How long will PTC Therapeutics (PTCT) Q3 2024 earnings call replay be available?

The replay of the earnings call will be available approximately two hours after completion and will be archived on the company's website for 30 days.